DC
FLGT icon

Diametric Capital’s Fulgent Genetics FLGT Stock Holding History

Diametric Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
697,784
+336,738
+93% +$5.71M 1.51% 4
2026
Q1 		$5.74M Buy
361,046
+160,886
+80% +$3.49M 1.49% 5
2025
Q4 		$5.26M Sell
200,160
-41,462
-17% -$1.08M 1.41% 6
2025
Q3 		$5.46M Buy
241,622
+72,648
+43% +$1.5M 2.02% 5
2025
Q2 		$3.36M Buy
+168,974
New +$3.29M 1.79% 6
2025
Q1 		– Sell
-38,818
Closed -$717K – 273
2024
Q4 		$717K Buy
+38,818
New +$758K 0.48% 58

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Diametric Capital's FLGT Position: Q2 2026 in Review

Diametric Capital increased its Fulgent Genetics (FLGT) stake by 93% in Q2 2026, buying an estimated $5.71M and bringing the position to 697,784 shares worth $14.3M. The position accounts for 1.51% of the portfolio, ranked #4.

Diametric Capital first reported a position in FLGT in Q4 2024 and has held it in 6 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Diametric Capital held 697,784 shares of Fulgent Genetics worth $14.3M as of Q2 2026.
  • Diametric Capital bought 336,738 Fulgent Genetics shares in Q2 2026, an estimated $5.71M.
  • Fulgent Genetics made up 1.51% of Diametric Capital's portfolio in Q2 2026, its #4 holding.
  • Diametric Capital first reported a position in Fulgent Genetics in Q4 2024 and has held it in 6 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.